Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06723158 · ClinicalTrials.gov registry record · NA
Oral Surgery Virtual Reality Glasses Study
A NA study of Procedural Pain and Procedural Anxiety, sponsored by Boston University.
- Recruiting
- Registry status
- NA
- Development phase
- 80
- Enrollment target
- 1
- Study location
NCT06723158: Recruiting NA study of Procedural Pain and Procedural Anxiety, sponsored by Boston University.
NCT06723158 is a NA study of Procedural Pain and Procedural Anxiety that is actively recruiting participants, run by Boston University. The registered enrollment target is 80 participants, above the 52-participant average among 9 other Procedural Pain trials with a reported enrollment target (54% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06723158, a NA study of Procedural Pain and Procedural Anxiety, is actively recruiting participants, sponsored by Boston University.
- RECRUITING
- Registry status
- NA
- Development phase
- 80 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this randomized trial is to investigate if using virtual reality (VR) glasses for patients who require non-emergent oral surgery procedures under intravenous (IV) sedation improves their overall experience compared to using standard of care safety glasses. This study has two primary objectives. 1. To evaluate if VR glasses can improve patient tolerance during IV access, sedation induction, and the surgical procedure. 2. To investigate whether the use of VR glasses reduces the amount of sedation required for induction and throughout the oral surgery procedure. 80 subjects will be randomly assigned 1:1 to either wear VR glasses playing a relaxing video and audio or VR glasses that will only serve as eye protection (control group).
Primary Outcome
Scores from the General Anxiety Disorder-7 (GAD-7) will be used to assess the level of anxiety. It is a 7-item instrument with each item scored from 0=Not at all to 3=Nearly every day. GAD-7 total scores for the can range from 0 to 21 with higher scores suggesting more anxiety. The scores are interpreted as 0-4: minimal anxiety, 5-9: mild anxiety, 10-14: moderate anxiety, and 15-21: severe anxiety.
Conditions Studied
Interventions
- OTHER Virtual reality (VR) glasses with relaxation module
Study Locations (1)
Massachusetts
- Goldman School of Dental Medicine, Oral and Maxillofacial Surgery Clinic - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2025-11-18 |
| Est. Completion | 2026-03 |
| Phase | NA |
What NCT06723158 shows while recruiting
NCT06723158 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 80 participants, a relatively small participant target, above the 52-participant average among 9 other Procedural Pain trials with a reported enrollment target (54% higher).
The record links to 2 conditions, with Procedural Pain appearing as the primary indexed condition, and to 1 intervention - of which Virtual reality (VR) glasses with relaxation module is the first listed.
NCT06723158 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT06723158 about?
NCT06723158 is a clinical study titled "Oral Surgery Virtual Reality Glasses Study". The goal of this randomized trial is to investigate if using virtual reality (VR) glasses for patients who require non-emergent oral surgery procedures under intravenous (IV) sedation improves their overall experience compared to using standard of care safety glasses. This study has two primary obj...
What is the current status of trial NCT06723158?
This trial is currently recruiting. It is a NA study. The enrollment target is 80 participants. The study started on 2025-11-18. Estimated completion is 2026-03.
What conditions does trial NCT06723158 study?
This clinical trial studies the following conditions: Procedural Pain, Procedural Anxiety.
What interventions are being tested in trial NCT06723158?
The interventions under investigation include: Virtual reality (VR) glasses with relaxation module (OTHER).
Who is sponsoring clinical trial NCT06723158?
This trial is sponsored by Boston University, which has 185 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06723158 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Procedural Pain
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06723158's enrollment target sits among peer trials
80 2nd of 9 the highest of 9 other Procedural Pain trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Procedural Pain trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Cervical Preparation for Same-Day Dilation & Evacuation
RECRUITING · NA
-
Trauma-Informed Procedural Pain Intervention: Refinement of an Evidence-Based Protocol
RECRUITING · NA
-
Virtual Reality for Pain Control in US-Guided Obstetric Needle Procedures
RECRUITING · NA
-
VR-PAT for Pain and Anxiety Management During Pediatric Dermatologic Laser Procedures
ACTIVE NOT RECRUITING · NA
-
Can Virtual Reality Reduce Pain and Anxiety During Blood Draw
COMPLETED · NA
-
Comparison of Compounded Topical Anesthetics
RECRUITING · Phase 4
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01243931 · 80 participants · NA
Optical Coherence Tomography Guided Transepithelial Phototherapeutic Keratectomy
- NCT01659203 · 80 participants · Phase 1
Proton or Photon RT for Retroperitoneal Sarcomas
- NCT01803451 · 80 participants · Early Phase 1
Glucagon-like Peptide 1, Glucose Metabolism and Gastric Bypass
- NCT01964859 · 80 participants · Phase 2
Feasibility Study for Fibroblast Autologous Skin Grafts
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI